Topic: Financials & Profitability

is this public? can be for payer or manufacturer

  • Perspective on National Coverage Analysis of CAR-T Therapies

    Perspective on National Coverage Analysis of CAR-T Therapies

  • Spending On Prescription Drugs In The US: Where Does All The Money Go?

    Spending On Prescription Drugs In The US: Where Does All The Money Go?

  • DPL responds to HHS Blueprint (May 16, 2018)

  • R&D Costs Do Not Explain Elevated U.S. Drug Prices

  • The U.S. Government Should Buy Gilead for $156Bn to Save Money on Hep C

  • Could High Drug Prices Be Bad for Innovation?